Optiver Holding’s Orphazyme A/S ORPH Stock Holding History

Optiver Holding’s Portfolio ORPH Stock Details ORPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-7,071	Closed	-$6K	–	587
2022 Q1	$6K	Sell	7,071 -99,765	-93%	-$167K	﹤0.01%	458
2021 Q4	$358K	Buy	106,836 +48,076	+82%	+$170K	﹤0.01%	262
2021 Q3	$242K	Buy	58,760 +54,615	+1,318%	+$281K	﹤0.01%	234
2021 Q2	$30K	Buy	+4,145	New	+$33.4K	﹤0.01%	321

Optiver Holding's ORPH Position: Q2 2022 in Review

Optiver Holding sold out of Orphazyme A/S (ORPH) in Q2 2022, closing a stake of 7,071 shares — an estimated $6K sold.

Optiver Holding first reported a position in ORPH in Q2 2021 and held it in 4 quarters. The position peaked at $358K in Q4 2021. 1 fund tracked by Wall St. Rank holds ORPH as of Q2 2022.

Optiver Holding reported no remaining Orphazyme A/S position as of Q2 2022 after selling out during the quarter.
Optiver Holding sold 7,071 Orphazyme A/S shares in Q2 2022, an estimated $6K.
Optiver Holding first reported a position in Orphazyme A/S in Q2 2021 and held it in 4 quarters.
Optiver Holding's Orphazyme A/S position peaked at $358K in Q4 2021.
1 fund tracked by Wall St. Rank held Orphazyme A/S as of Q2 2022.

Based on Optiver Holding's 13F filing for Q2 2022, filed 10 Aug 2022.